Lv11
40 积分 2023-03-23 加入
CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy
5小时前
待确认
The APOB polymorphism rs1801701 A/G (p.R3638Q) is an independent risk factor for early-onset coronary artery disease: Data from a Spanish cohort
5天前
已完结
Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy
24天前
已完结
Non-invasive evaluation of NAFLD and the contribution of genes: an MRI-PDFF-based cross-sectional study
26天前
已完结
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial
2个月前
已完结
Efficient and Safe In Vivo Treatment of Primary Hyperoxaluria Type 1 via LNP-CRISPR/Cas9-mediated glycolate oxidase disruption
2个月前
已完结
Heterozygous familial hypercholesterolemia: prevalence and control rates
4个月前
已完结
Lipoprotein apheresis for lipoprotein(a) and cardiovascular disease
4个月前
已完结
Two founder mutations in the LDL receptor gene in Norwegian familial hypercholesterolemia subjects
4个月前
已完结
Lipoprotein(a) and Long-Term Recurrent Infarction After an Acute Myocardial Infarction
4个月前
已完结
皖公网安备34019202002308
